Hyperfine (HYPR) Times Interest Earned (2021 - 2026)

Hyperfine's (HYPR) quarterly Times Interest Earned came in at -$103.11 in Q1 2026, down 427.11% on a QoQ basis from -$19.56 in Q4 2025.

Hyperfine (HYPR) Times Interest Earned (2021 - 2026) Analysis & Trends

Hyperfine (HYPR) has 6 years of Times Interest Earned data on file, last reported at -$103.11 in Q1 2026.

Quarterly Times Interest Earned changed N/A year-over-year to -$103.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$418.57 (changed N/A YoY) and the FY2025 annual result came in at -$65.06, up 61.47% from the prior year.
Times Interest Earned eased to -$103.11 in Q1 2026, from -$19.56 in the prior quarter.
In the past five years, Times Interest Earned ranged from a high of -$0.19 in Q4 2023 to a low of -$221.88 in Q1 2024.
A 5-year average of -$100.44 and a median of -$94.96 in 2022 frame the typical range for Times Interest Earned.
Annual changes were most pronounced in 2023 — Times Interest Earned surged 99.78% — and 2024, when it tumbled 21891.59%.
Tracing HYPR's Times Interest Earned over 5 years: stood at -$86.81 in 2022, then surged by 99.78% to -$0.19 in 2023, then plunged by 21891.59% to -$42.05 in 2024, then surged by 53.48% to -$19.56 in 2025, then tumbled by 427.11% to -$103.11 in 2026.
The last three Times Interest Earned figures came in at -$103.11 (Q1 2026), -$19.56 (Q4 2025), and -$42.05 (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	4.82
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	11.77
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	10.64
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	12.27
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	-
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	6.48
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	-8.96
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	18.09
10	Hyperfine	89.83 Mn	45.06 Mn	1.98 Mn	-15.89

Download Data